XML 47 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Based Compensation - Summary of RSU Activity (Detail) - RSUs [Member]
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Unvested Shares, Beginning Balance | shares 5,619,438
Granted | shares 391,021
Vested and issued | shares (865,072)
Cancelled | shares (612,472)
Unvested Shares, Ending Balance | shares 4,532,915
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 5.9
Weighted Average Grant Date Fair Value, Granted | $ / shares 2.02
Weighted Average Grant Date Fair Value, Vested and issued | $ / shares 6.14
Weighted Average Grant Date Fair Value, Cancelled | $ / shares 6.4
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 5.45
Service Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Unvested Shares, Beginning Balance | shares 5,102,268
Granted | shares 391,021
Vested and issued | shares (865,072)
Cancelled | shares (595,286)
Unvested Shares, Ending Balance | shares 4,032,931
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 6.04
Weighted Average Grant Date Fair Value, Granted | $ / shares 2.02
Weighted Average Grant Date Fair Value, Vested and issued | $ / shares 6.14
Weighted Average Grant Date Fair Value, Cancelled | $ / shares 6.06
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 5.62
Performance Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Unvested Shares, Beginning Balance | shares 517,170
Granted | shares 0
Vested and issued | shares 0
Cancelled | shares (17,186)
Unvested Shares, Ending Balance | shares 499,984
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 4.54
Weighted Average Grant Date Fair Value, Granted | $ / shares 0
Weighted Average Grant Date Fair Value, Vested and issued | $ / shares 0
Weighted Average Grant Date Fair Value, Cancelled | $ / shares 18.33
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 4.06